Scholar Rock Holding (SRRK) Assets (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Assets of $535.3 million in Q1 2026, up 32.4% quarter-over-quarter from $404.3 million in Q4 2025, and up 31.33% on a YoY basis from $407.6 million in Q1 2025.
Scholar Rock Holding (SRRK) Assets (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Assets history runs 10 years deep, the most recent figure standing at $535.3 million for Q1 2026.
- In Q1 2026, Assets rose 31.33% year-over-year to $535.3 million; the TTM figure through Mar 2026 stood at $535.3 million (up 31.33% YoY), while the FY2025 annual figure was $404.3 million, down 14.88% from the prior year.
- Assets was $535.3 million for Q1 2026 at Scholar Rock Holding, up from $404.3 million in the prior quarter.
- In the past five years, Assets ranged from a high of $535.3 million in Q1 2026 to a low of $179.1 million in Q3 2024.
- Historically, Assets has averaged $343.9 million across 5 years, with a median of $340.0 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Assets tumbled 35.77% in 2023, then surged 129.84% in 2025.
- A 5-year view of Assets shows it stood at $358.2 million in 2022, then slipped by 13.16% to $311.0 million in 2023, then jumped by 52.69% to $474.9 million in 2024, then slipped by 14.88% to $404.3 million in 2025, then surged by 32.4% to $535.3 million in 2026.
- The last three Assets figures came in at $535.3 million (Q1 2026), $404.3 million (Q4 2025), and $411.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 37.37 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 811.27 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 14.93 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.73 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 23.64 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 33.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 12.81 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.48 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 640.56 Mn |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 535.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 535.25 Mn |
| Dec 31, 2025 | 404.27 Mn |
| Sep 30, 2025 | 411.72 Mn |
| Jun 30, 2025 | 340.05 Mn |
| Mar 31, 2025 | 407.55 Mn |
| Dec 31, 2024 | 474.92 Mn |
| Sep 30, 2024 | 179.13 Mn |
| Jun 30, 2024 | 226.87 Mn |
| Mar 31, 2024 | 267.29 Mn |
| Dec 31, 2023 | 311.04 Mn |
| Sep 30, 2023 | 250.69 Mn |
| Jun 30, 2023 | 284.90 Mn |
| Mar 31, 2023 | 314.72 Mn |
| Dec 31, 2022 | 358.17 Mn |
| Sep 30, 2022 | 390.30 Mn |
| Jun 30, 2022 | 424.13 Mn |
| Mar 31, 2022 | 265.98 Mn |
| Dec 31, 2021 | 304.45 Mn |
| Sep 30, 2021 | 298.39 Mn |
| Jun 30, 2021 | 332.05 Mn |